Related Experiment Video
Updated: Feb 11, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Kristina J Allan1, Douglas J Mahoney2, Stephen D Baird3
1Children's Hospital of Eastern Ontario (CHEO) Research Institute; Department of Biology, Microbiology and Immunology, University of Ottawa.
Abstract:
High-throughput genome-wide RNAi (RNA interference) screening technology has been widely used for discovering host factors that impact virus replication. Here we present the application of this technology to uncovering host targets that specifically modulate the replication of Maraba virus, an oncolytic rhabdovirus, and vaccinia virus with the goal of enhancing therapy. While the protocol has been tested for use with oncolytic Maraba virus and oncolytic vaccinia virus, this approach is applicable to other oncolytic viruses and can also be utilized for identifying host targets that modulate virus replication in mammalian cells in general. This protocol describes the development and validation of an assay for high-throughput RNAi screening in mammalian cells, the key considerations and preparation steps important for conducting a primary high-throughput RNAi screen, and a step-by-step guide for conducting a primary high-throughput RNAi screen; in addition, it broadly outlines the methods for conducting secondary screen validation and tertiary validation studies. The benefit of high-throughput RNAi screening is that it allows one to catalogue, in an extensive and unbiased fashion, host factors that modulate any aspect of virus replication for which one can develop an in vitro assay such as infectivity, burst size, and cytotoxicity. It has the power to uncover biotherapeutic targets unforeseen based on current knowledge.
Insights
High-throughput RNA interference (RNAi) screening identifies host factors influencing Maraba and vaccinia virus replication. This unbiased approach aids in discovering novel biotherapeutic targets for enhancing oncolytic virus therapy.
Area of Science:
- Virology
- Genetics
- Biotechnology
Background:
- High-throughput genome-wide RNA interference (RNAi) screening is crucial for identifying host factors affecting virus replication.
- Oncolytic viruses like Maraba and vaccinia virus are promising therapeutic agents.
Purpose of the Study:
- To apply high-throughput RNAi screening to discover host targets modulating Maraba and vaccinia virus replication.
- To enhance oncolytic virus therapy by identifying key host-virus interactions.
Main Methods:
- Development and validation of a high-throughput RNAi screening assay in mammalian cells.
- Detailed protocol for primary, secondary, and tertiary screens to identify host factors.
- Utilizing in vitro assays for infectivity, burst size, and cytotoxicity to measure viral replication.
Main Results:
- Successful application of the RNAi screening protocol to identify host factors impacting Maraba and vaccinia virus replication.
- Demonstration of the protocol's applicability to other oncolytic viruses and general virus-host interaction studies.
- Cataloguing of host factors that modulate various aspects of viral replication in an unbiased manner.
Conclusions:
- High-throughput RNAi screening provides an extensive and unbiased method for discovering host factors critical for virus replication.
- This technology can uncover novel biotherapeutic targets for enhancing oncolytic virotherapy.
- The developed protocol is adaptable for a wide range of oncolytic viruses and general host-pathogen interaction studies.
Related Concept Videos
What are Viruses?
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Viruses with RNA Genomes
Gene Therapy
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Genomics

